Universal Beteiligungs und Servicegesellschaft mbH Purchases New Position in Veeva Systems Inc. (NYSE:VEEV)

Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of Veeva Systems Inc. (NYSE:VEEV - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 204,762 shares of the technology company's stock, valued at approximately $43,051,000. Universal Beteiligungs und Servicegesellschaft mbH owned about 0.13% of Veeva Systems at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Cardinal Capital Management grew its position in shares of Veeva Systems by 0.3% in the 4th quarter. Cardinal Capital Management now owns 15,727 shares of the technology company's stock worth $3,307,000 after buying an additional 44 shares during the last quarter. Johnson Financial Group Inc. grew its position in shares of Veeva Systems by 22.7% in the 4th quarter. Johnson Financial Group Inc. now owns 238 shares of the technology company's stock worth $56,000 after buying an additional 44 shares during the last quarter. Patriot Financial Group Insurance Agency LLC grew its position in shares of Veeva Systems by 0.7% in the 4th quarter. Patriot Financial Group Insurance Agency LLC now owns 6,975 shares of the technology company's stock worth $1,467,000 after buying an additional 51 shares during the last quarter. Old North State Wealth Management LLC grew its position in shares of Veeva Systems by 0.4% in the 4th quarter. Old North State Wealth Management LLC now owns 15,351 shares of the technology company's stock worth $3,228,000 after buying an additional 55 shares during the last quarter. Finally, Colonial Trust Co SC boosted its position in shares of Veeva Systems by 30.3% during the fourth quarter. Colonial Trust Co SC now owns 241 shares of the technology company's stock valued at $51,000 after purchasing an additional 56 shares in the last quarter. 88.20% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. Stephens restated an "overweight" rating and set a $280.00 price target on shares of Veeva Systems in a research report on Thursday, March 6th. JPMorgan Chase & Co. lifted their price target on Veeva Systems from $218.00 to $249.00 and gave the company a "neutral" rating in a research report on Thursday, March 20th. Raymond James lifted their price target on Veeva Systems from $285.00 to $310.00 and gave the company an "outperform" rating in a research report on Thursday. Wall Street Zen upgraded Veeva Systems from a "hold" rating to a "buy" rating in a research report on Monday, February 17th. Finally, UBS Group lifted their price target on Veeva Systems from $250.00 to $285.00 and gave the company a "neutral" rating in a research report on Thursday. Two analysts have rated the stock with a sell rating, eight have issued a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $269.00.

Veeva Systems Price Performance

Shares of VEEV traded up $0.99 during trading hours on Friday, hitting $280.03. The stock had a trading volume of 3,578,987 shares, compared to its average volume of 1,150,622. Veeva Systems Inc. has a 12 month low of $170.25 and a 12 month high of $285.70. The firm has a market capitalization of $45.56 billion, a PE ratio of 69.14, a PEG ratio of 1.89 and a beta of 0.96. The stock has a fifty day moving average price of $229.69 and a 200 day moving average price of $227.56.

Veeva Systems (NYSE:VEEV - Get Free Report) last issued its quarterly earnings data on Wednesday, May 28th. The technology company reported $1.97 EPS for the quarter, topping the consensus estimate of $1.74 by $0.23. Veeva Systems had a return on equity of 13.56% and a net margin of 25.07%. The company had revenue of $759.04 million during the quarter, compared to analyst estimates of $728.38 million. During the same quarter in the previous year, the company posted $1.50 earnings per share. Veeva Systems's revenue was up 16.7% compared to the same quarter last year. As a group, analysts anticipate that Veeva Systems Inc. will post 4.35 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, insider Thomas D. Schwenger sold 1,200 shares of the company's stock in a transaction dated Monday, April 14th. The stock was sold at an average price of $220.97, for a total value of $265,164.00. Following the completion of the transaction, the insider now owns 25,889 shares of the company's stock, valued at $5,720,692.33. This represents a 4.43% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, SVP Jonathan Faddis sold 787 shares of the company's stock in a transaction dated Wednesday, April 2nd. The stock was sold at an average price of $226.20, for a total value of $178,019.40. Following the completion of the transaction, the senior vice president now directly owns 8,668 shares of the company's stock, valued at approximately $1,960,701.60. This trade represents a 8.32% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 5,869 shares of company stock worth $1,284,917. Company insiders own 10.30% of the company's stock.

Veeva Systems Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.